SCHEMBL282020

SCHEMBL282020

Cc1cc(Br)c(C)cc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.55
KDM4E B2RXH2 2/20 0.55
MAPT P10636 2/20 0.55
CYP3A4 P08684 2/20 0.55
ALDH1A1 P00352 1/20 0.55
CYP1A2 P05177 1/20 0.55
CYP2D6 P10635 1/20 0.55
G6PD P11413 1/20 0.55
CYP2C9 P11712 1/20 0.55
PKM P14618 1/20 0.55
HPGD P15428 1/20 0.55
ALOX12 P18054 1/20 0.55
MAPK1 P28482 1/20 0.55
CYP2C19 P33261 1/20 0.55
CCR6 P51684 1/20 0.55
HIF1A Q16665 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
HSD17B10 Q99714 1/20 0.55
TDP1 Q9NUW8 2/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30283411 0.89 ALOX15 (0.48) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL482183 0.89 ALOX15 (0.48) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL23230056 0.86 ALOX15 (0.50) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL68996 0.86 ALOX15 (0.43) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL1146850 0.83 ALOX15 (0.55) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL12572587 0.83 ALOX15 (0.48) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL10907457 0.83 ALOX15 (0.42) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL6743198 0.83 ALOX15 (0.40) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL29446755 0.83 ALOX15 (0.55) ALOX15KDM4EMAPTCYP3A4ALDH1A1
SCHEMBL120851 0.82 ALDH1A1 (0.42) CYP3A4ALDH1A1HPGDMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118240200-A Low-dielectric fluorine-containing polyarylether resin and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2024-06-25 CN claimed
CN-113527618-B Preparation method and application of flame-retardant flatulence slow-rebound combined polyether polyol 南京金栖化工集团有限公司 2022-11-01 CN claimed
CN-113527618-A Preparation method and application of flame-retardant flatulence slow-rebound combined polyether polyol 南京金栖化工集团有限公司 2021-10-22 CN claimed
US-12269814-B2 Process for preparing a compound useful to treat mycoses PULMOCIDE LIMITED (GB) 2025-04-08 US disclosed
WO-2025070947-A1 NOVEL PHTHALAZINE DERIVATIVE COMPOUND AS SOS1 INHIBITOR, AND USE THEREOF 한미약품 주식회사 2025-04-03 WO disclosed
EP-4511114-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN Vertex Pharmaceuticals Incorporated (US) 2025-02-26 EP disclosed
CN-118240200-A Low-dielectric fluorine-containing polyarylether resin and preparation method and application thereof 中国科学院宁波材料技术与工程研究所 2024-06-25 CN disclosed
CN-114805054-B Synthesis method of gemfibrozil Ji Xiu derivative 浙江精进药业有限公司 2024-05-28 CN disclosed
US-11905230-B2 Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament CHINA PHARMACEUTICAL UNIVERSITY (CN) 2024-02-20 US disclosed
US-20230382910-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED 2023-11-30 US disclosed
US-20230382910-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED 2023-11-30 US disclosed
EP-1891080-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS Metabasis Therapeutics, Inc. (US) 2008-02-27 EP disclosed
EP-1890768-A2 NOVEL PHOSPHINIC ACID-CONTAINING THYROMIMETICS Metabasis Therapeutics, Inc. (US) 2008-02-27 EP disclosed
CN-1882327-A Novel phosphorus-containing thyromimetics METABASIS THERAPEUTICS INC (US) 2006-12-20 CN disclosed
WO-2006128056-A2 NOVEL PHOSPHINIC ACID-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS, INC. (US) 2006-11-30 WO disclosed
WO-2006128055-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS, INC. (US) 2006-11-30 WO disclosed
EP-1689383-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS Metabasis Therapeutics, Inc. (US) 2006-08-16 EP disclosed
US-20060074102-A1 Kinase inhibitors as therapeutic agents ABBOTT LABORATORIES 2006-04-06 US disclosed
US-20060046980-A1 Novel phosphorus-containing thyromimetics METABASIS THERAPEUTICS, INC. 2006-03-02 US disclosed
WO-2005051298-A2 NOVEL PHOSPHORUS-CONTAINING THYROMIMETICS METABASIS THERAPEUTICS, INC. (US) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060074102-A1 Kinase inhibitors as therapeutic agents ABL1, MAP3K19, MAP3K20 ALOX15 4734/4885KDM4E 965/4885MAPT 2339/4885
US-11905230-B2 Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament SLC5A1, PYGL, GPR119 ALOX15 691/4885KDM4E 995/4885MAPT 2913/4885
US-20060046980-A1 Novel phosphorus-containing thyromimetics PYGL, THRA, THOP1 ALOX15 1968/4885KDM4E 4102/4885MAPT 3512/4885
US-20230382910-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN TRPV1, SCN3A, KCNN3 ALOX15 694/4885KDM4E 4346/4885MAPT 2089/4885
US-12269814-B2 Process for preparing a compound useful to treat mycoses C1R, CBR1, CBR3 ALOX15 2400/4885KDM4E 2809/4885MAPT 4726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.